Saturday, August 9, 2025, marked one yr for the reason that approval of neffy, the primary needle-free remedy for extreme allergic reactions.
HCPLive spoke with quite a few consultants on the influence of a needle-free epinephrine choice for extreme allergic reactions. This function contains the views of:
- Matthew Greenhawt, MD, MBA, MSc: CMO of Bronchial asthma and Allergy Basis of America (AAFA)
- Brian Schroer, MD: Allergist immunologist on the Cleveland Clinic Kids’s Hospital
- Colleen Kraft, MD, MBA: Medical professor of Pediatrics on the Keck College of Drugs of USC and an attending doctor on the Kids’s Hospital Los Angeles
- Ryan Haumschild, PharmD, MS, MBA: Vice President of Pharmacy at Emory Healthcare and Winship Most cancers Institute
- Thomas Casale, MD: Professor of Drugs at College of South Florida in Tampa
Observe of Disclosure: ARS Pharma — the corporate that developed and commercializes neffy — is an advertiser with SnackSafely.com.
